Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

20 mars 2026 10h48 HE | Source: Longeviti Neuro Solutions

Longeviti Neuro Solutions Appoints T. Rowe Price CEO Robert W. Sharps to Board of Directors

T. Rowe Price CEO Robert Sharps joins Longeviti Neuro Solutions board, signaling growth as the company scales its AI-enabled neurotechnology platform.
19 mars 2026 09h25 HE | Source: Aclarion, Inc.

Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan
19 mars 2026 07h05 HE | Source: NeurAxis, Inc.

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

CARMEL, Ind., March 19, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for...
19 mars 2026 06h00 HE | Source: Aclarion, Inc.

Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts

Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts
18 mars 2026 08h30 HE | Source: SS Innovations

SS Innovations’ SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines

SS Innovations’ SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines
18 mars 2026 08h30 HE | Source: WallabyPhenox

WallabyPhenox Restructures Debt and Accelerates Global Growth

WallabyPhenox completes financing to strengthen its balance sheet, support global expansion, and advance major neurovascular clinical programs.
17 mars 2026 06h00 HE | Source: Aclarion, Inc.

Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet

Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet
12 mars 2026 11h18 HE | Source: Research and Markets

Medical Devices Distribution Partnering Agreements Report and Directory 2016-2026: Insights Into How Companies Structure Distribution Deals, Negotiate Financial Terms, and Expand Market Access

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Distribution Deals in Medical Devices 2016 to 2026" report has been added to ResearchAndMarkets.com's offering.This latest Distribution Deals in...
12 mars 2026 09h00 HE | Source: NeurAxis, Inc.

NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026

CARMEL, Ind., March 12, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies...
11 mars 2026 16h05 HE | Source: BioStem Technologies, Inc.

BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026

BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026

Page suivante